Jungjoon K. Lee

Dr. Jungjoon K. Lee received his Ph.D. in chemistry from Stanford University in 2011 under the theme of Directed Evolution, and BA/MSci degrees in Natural Science (Chemistry) from the University of Cambridge in 2005. After that, he worked in the Future Biotherapeutics department of Samsung Advanced Institute of Technology for three years and worked as a research scientist at Seoul National University's The Institute of Molecular Biology & Genetics for two years to conduct research in CRISPR-Cas9. After that, he joined Toolgen in 2016 and worked at the Platform development team and published a number of papers and patents related to the CRISPR platform. His representative achievements include the development of several groundbreaking tools, such as the first Genome-wide off-target detection method for Prime Editor TAPE-seq (Nature Communications 2022), the standardized Genome-wide off-target detection method Extru-seq (Genome Biology 2023), and the high-fidelity Cas9 with high activity, Sniper2L (Nature Chemical Biology 2023).